Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Beacon Biosignals
AddedFeb 17, 2024
UpdatedJun 18, 2026
Beacon Biosignals

Beacon Biosignals

Series A

Beacon Biosignals: Enhancing human health with AI-powered brain activity analysis.

HQ
Boston, MA, US
Founded
2019
Overview
Compare
Fundraising
Employees
Website

Beacon Biosignals, founded with the mission to enhance human health through AI-powered analysis of brain activity, focuses on improving the speed and accuracy of EEG reports. The company offers a neurobiomarker platform designed to accelerate clinical trials and enable new treatments for neurological and psychiatric diseases. Their services include quantitative assessment of treatment efficacy and dose selection, leveraging advanced AI to streamline clinical endpoints.

Notable figures affiliated with Beacon Biosignals include experts in neurology and AI, though specific names are not provided. The company has achieved significant milestones in delivering rapid and precise EEG reports, eliminating the need for traditional adjudication processes. Beacon Biosignals has made a substantial impact on the precision medicine landscape, particularly in the realm of neurological and psychiatric conditions, by enabling more efficient and effective clinical trials.

Beacon Biosignals - Similar Companies

Brainify.AI logo

Brainify.AI

brainify.ai

BioSignal Analytics logo

BioSignal Analytics

Beacon logo

Beacon

Beaconcure logo

Beaconcure

beaconcure.com

BioAI Health logo

BioAI Health

bioaihealth.com

Beacon logo

Beacon

sendbeacon.com

Vistim Labs logo

Vistim Labs

vistimlabs.com

CNS Response logo

CNS Response

NovaSignal logo

NovaSignal

novasignal.com

Neuroview Technology logo

Neuroview Technology

neuroviewtech.com

BioSig AI Sciences logo

BioSig AI Sciences

Alto Neuroscience logo

Alto Neuroscience

Beacons logo

Beacons

beacons.ai

NeuroSpire logo

NeuroSpire

neurospire.com

Bios Health logo

Bios Health

bios.health

Beacon Biosignals - Quick Facts

Who are Beacon Biosignals' competitors?

Companies similar to Beacon Biosignals include Brainify.AI, BioSignal Analytics, Beacon and Beaconcure.

When was Beacon Biosignals founded?

Beacon Biosignals was founded in 2019.

Where is Beacon Biosignals' headquarters located?

Beacon Biosignals' headquarters is located in Boston, MA, US.

When was Beacon Biosignals' last funding round?

Beacon Biosignals' most recent funding round was for $27M (USD) in November 2021.

How much has Beacon Biosignals raised to-date?

As of Nov 8, 2021, Beacon Biosignals has raised a total of $30M (USD).

How many employees does Beacon Biosignals have?

Beacon Biosignals has 56 employees as of Feb 5, 2024.

Beacon Biosignals - Classification

Ownership
  • Venture Capital
Technology
  • AI
Geographic Exposure
  • Global
Model
  • Platform
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • EEG Reports
Tags
  • Biotech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 5 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7372Prepackaged Software